-0.13 | -0.64%
| Price and Volume | |
|---|---|
| Recent Price | 20.39 |
| 52 Week High | 33.17 |
| 52 Week Low | 14.62 |
| Avg. Daily Vol. (Mil) | 1.51 |
| Beta (3 year) | 1.43 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,421.81 |
| Shares Out (Mil) | 69.73 |
| Float (Mil) | 46.88 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.20 |
| Current Ratio | 6.10 |
| LT Debt/ Equity | 0.18 |
| Total Debt / Equity | 0.18 |
| Valuation Ratios | |
| Price Earnings | 13.30 |
| Price/Sales | 2.57 |
| Price/Book | 1.62 |
| Price/Cash Flow | 8.90 |
| Per Share Data | |
| Earnings | 1.53 |
| Sales | 7.93 |
| Book Value | 12.58 |
| Cash Flow | 2.28 |
| Business Summary | |
|---|---|
| ViroPharma, Inc. company dedicated to the development and commercialization of products that address serious diseases, with a focus on products used by physician specialists or in hospital settings. | |
| General Information | |
| 730 Stockton Drive
Exton, PA 19341 |
|
| www.viropharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 311 | |
| CEO: Vincent J. Milano | |
| Short Interest | |
| Current Month (Mil) | 9.54 |
| Previous Month (Mil) | 9.68 |
| Short Interest Ratio (Days) | 5.90 |
| Management Effectiveness | |
| Return on Equity | 14.20 |
| Return on Assets | 9.30 |
| Return on Investments | 12.00 |
| Profitability | |
| Gross Margin | 83.80 |
| EBIT Margin | 35.90 |
| Profit Margin | 22.50 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.00
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |
Connect with TheStreet